Comprehensive rehabilitation treatment for sub-acute COVID-19 patients: an observational study

被引:19
|
作者
Bertolucci, Federica [1 ]
Sagliocco, Laura [1 ]
Tolaini, Martina [1 ]
Posteraro, Federico [1 ]
机构
[1] AUSL Toscana Nord Ovest, Dept Rehabil, Versilia Hosp, Via Aurelia 335, I-55041 Camaiore, Lucca, Italy
关键词
COVID-19; SARS-CoV-2; Disability evaluation; Rehabilitation; Pandemics; FIELD; UPDATE; 31ST;
D O I
10.23736/S1973-9087.21.06674-0
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
BACKGROUND: COVID-19 is a respiratory infection, but it should be considered as a systemic illness with increasing interest on the survivors' sequelae and their management. Considering multi-organ disabilities, a comprehensive rehabilitation provided in sub-acute phase could be considered a suitable setting for these patients. AIM: The aim of this article was to report the features and rehabilitative outcomes of patients requiring rehabilitation due to disabilities related to severe COVID-19 infection. DESIGN: Longitudinal Observational Study. SETTING: Department of Rehabilitation in General Hospital. POPULATION : Patients showing multiple disabilities due to severe COVID-19 infection. METHODS: Thirty-nine consecutive patients were admitted to a rehabilitation ward transferred from ICU or Medical wards. Barthel Index (BI) and Functional Ambulation Categories (FAC) were scored as disabilities measures. Data regarding comorbidity, rehabilitation course, swabs, procedures in acute phase, non-respiratory manifestations, dysphagia, mental confusion, PaO2/FiO2, oxygen supplementation have been collected to admission and discharge. For all patients a comprehensive rehabilitation treatment have been provided. RESULTS: Functional outcome is good with a statistically significant improvement in BI and FAC scores. Thirty-eight patients were discharged at their home. Mean lenght of stay (LOS) in acute wards was 46 days. Mean LOS in rehabilitation was 20 day. Eleven patients still had tracheostomy at admission, none at discharge and all dysphagic patients recovered a normal oral feeding. The change in PaO2/FiO2 and the reduction of the oxygen supplementation testify a good recovery of pulmonary function. CONCLUSIONS: Our results showed a consistent recovery with little caregiver burden at discharge. Fast relocation from ICU makes beds available which are very valuable during pandemic. Comprehensive rehabilitation treatment provided in sub-acute phase for patients still positive for SARS-CoV-2, would be desirable as it seems to be an effective setting. In this setting a strong medical assistance must be ensured. CLINICAL REHABILITATION IMPACT : The activation of comprehensive rehabilitation settings able to assist sub-acute patients still positive would be desirable as it could be a very efficient Healthcare Systems answer to the catastrophic pandemic, decompressing acute hospital as well. Furthermore, contagious patients with swabs positivity affected by other kind of disabilities (i.e. Stroke, Femur Fracture) can be treated avoiding to lose the early rehabilitation.
引用
收藏
页码:208 / 215
页数:8
相关论文
共 50 条
  • [21] Comment on: Early rehabilitation in post-acute COVID-19 patients: data from an Italian COVID-19 rehabilitation unit and proposal of a treatment protocol
    Rivera-Lillo, Gonzalo
    Torres-Castro, Rodrigo
    Puppo, Homero
    Vilaro, Jordi
    [J]. EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, 2021, 57 (01) : 171 - 172
  • [22] Rehabilitation of patients with COVID-19
    Sun, Tiantian
    Guo, Liyun
    Tian, Fei
    Dai, Tiantian
    Xing, Xiaohong
    Zhao, Junqing
    Li, Qiang
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2020, 14 (12) : 1249 - 1256
  • [23] REHABILITATION OF COVID-19 PATIENTS
    Brugliera, Luigia
    Spina, Alfio
    Castellazzi, Paola
    Cimino, Paolo
    Tettamanti, Andrea
    Houdayer, Elise
    Arcuri, Pietro
    Alemanno, Federica
    Mortini, Pietro
    Iannaccone, Sandro
    [J]. JOURNAL OF REHABILITATION MEDICINE, 2020, 52 (04)
  • [24] Tocilizumab treatment in critically ill patients with COVID-19: A retrospective observational study
    Huang, Edmund
    Isonaka, Sharon
    Yang, Haoshu
    Salce, Erin
    Rosales, Elisa
    Jordan, Stanley C.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 245 - 251
  • [25] Tocilizumab treatment for patients with Covid-19 pneumonia - a single centre observational study
    Gologanu, Daniela Stefana
    Micu, Victorita
    Nedelcu, Valentin
    Ion, Andrei Ion
    Balea, Marius Ioan
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [26] The Impact of Comprehensive Rehabilitation on the Exercise Capacity of Patients after COVID-19
    Minko, Alicja
    Turon-Skrzypinska, Agnieszka
    Ryl, Aleksandra
    Rotter, Iwona
    [J]. ADVANCES IN RESPIRATORY MEDICINE, 2023, 91 (06) : 504 - 515
  • [27] Rehabilitation of COVID-19 patients with respiratory failure and critical illness disease in Slovenia: an observational study
    Novak, Primoz
    Cunder, Katarina
    Petrovic, Olga
    Oblak, Tina
    Dular, Katja
    Zupanc, Aleksander
    Prosic, Zdenka
    Majdic, Neza
    [J]. INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 2022, 45 (01) : 65 - 71
  • [28] Use of traditional Chinese medicine for the treatment and prevention of COVID-19 and rehabilitation of COVID-19 patients: An evidence mapping study
    Li, Yanfei
    Qin, Yu
    Chen, Nan
    Ge, Long
    Wang, Qi
    Aboudou, Taslim
    Han, Jiani
    Hou, Liangying
    Cao, Liujiao
    Li, Rui
    Li, Meixuan
    Mi, Ningning
    Xie, Peng
    Wu, Siqing
    Hu, Linmin
    Li, Xiuxia
    Song, Zhongyang
    Ji, Jing
    Zhang, Zhiming
    Yang, Kehu
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [29] Oral manifestations in COVID-19 patients: A observational study
    Muthyam, Alka Kumari
    Reddy, M. Padma
    Kulkarni, Suhas
    Srilatha, Adepu
    Sahithi, Kommuri
    Satyanarayana, Dantala
    [J]. JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (03) : 1000 - 1005
  • [30] Observational Study of Chlorpromazine in Hospitalized Patients with COVID-19
    Nicolas Hoertel
    Marina Sánchez-Rico
    Raphaël Vernet
    Anne-Sophie Jannot
    Antoine Neuraz
    Carlos Blanco
    Cédric Lemogne
    Guillaume Airagnes
    Nicolas Paris
    Christel Daniel
    Alexandre Gramfort
    Guillaume Lemaitre
    Mélodie Bernaux
    Ali Bellamine
    Nathanaël Beeker
    Frédéric Limosin
    [J]. Clinical Drug Investigation, 2021, 41 : 221 - 233